Induction of resistance to fluorodeoxyuridine cytotoxicity and DNA damage in human tumor cells by expression of Escherichia coli deoxyuridinetriphosphatase.
Recent studies from our laboratory suggested that, in some human colorectal tumor cell lines, sensitivity to fluorodeoxyuridine may depend upon the extent of dUTP accumulation that occurs following drug treatment and that elevation of dUTPase activity might be the basis for some instances of resistance to fluoropyrimidines. To test this model, we expressed Escherichia coli dUTPase in an established human tumor cell line (HT29) and measured the effect of this manipulation on response to fluorodeoxyuridine. As predicted, HT29 derivatives containing dUTPase activity 4-5-fold higher than controls were protected from fluorodeoxyuridine-induced loss of clonogenicity and from formation of DNA double strand breaks. These data provide the first direct evidence that alteration in a component of the uracil misincorporation/misrepair pathway can confer resistance to fluoropyrimidines in human tumor cells.
Canman
C E
CE
Department of Pharmacology 48109-0504.
Radany
E H
EH
Parsels
L A
LA
Davis
M A
MA
Lawrence
T S
TS
Maybaum
J
J
D001483:Base Sequence; D004249:DNA Damage; D004351:Drug Resistance; D004926:Escherichia coli / Q000201:enzymology*; D005467:Floxuridine / Q000494:pharmacology*; D006801:Humans; D008969:Molecular Sequence Data; D011755:Pyrophosphatases / Q000737:chemistry / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D005467:Floxuridine; D011755:Pyrophosphatases; C020020:dUTP pyrophosphatase